

浏览全部资源
扫码关注微信
北京中医药大学 中药学院,北京 102488
Received:25 September 2024,
Accepted:15 November 2024,
Published Online:29 November 2024,
Published:05 April 2025
移动端阅览
阮意丹,张慧中,黄华婷等.葫芦素B诱导细胞铁死亡抑制乳腺癌4T1细胞增殖作用及机制[J].中国实验方剂学杂志,2025,31(07):91-97.
RUAN Yidan,ZHANG Huizhong,HUANG Huating,et al.Role and Mechanism of Cucurbitacin B in Suppressing Proliferation of Breast Cancer 4T1 Cells via Inducing Ferroptosis[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(07):91-97.
阮意丹,张慧中,黄华婷等.葫芦素B诱导细胞铁死亡抑制乳腺癌4T1细胞增殖作用及机制[J].中国实验方剂学杂志,2025,31(07):91-97. DOI: 10.13422/j.cnki.syfjx.20250126.
RUAN Yidan,ZHANG Huizhong,HUANG Huating,et al.Role and Mechanism of Cucurbitacin B in Suppressing Proliferation of Breast Cancer 4T1 Cells via Inducing Ferroptosis[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(07):91-97. DOI: 10.13422/j.cnki.syfjx.20250126.
目的
2
探讨葫芦素B(CuB)诱导4T1细胞发生铁死亡作用及其机制。
方法
2
采用噻唑蓝(MTT)比色法检测CuB(0.2、0.4、0.8 μmol·L
-1
)对4T1细胞体外增殖能力的影响;平板克隆实验检测4T1细胞克隆形成能力;利用试剂盒检测4T1细胞中乳酸脱氢酶(LDH)的含量;流式细胞仪检测4T1细胞中线粒体膜电位和活性氧(ROS)水平;透射电镜观察4T1细胞的线粒体超微结构;采用蛋白免疫印迹法检测4T1细胞中铁死亡相关蛋白p53、溶质载体家族7成员11(SCL7A11)、谷胱甘肽过氧化物酶4(GPX4)、长链脂酰辅酶A合成酶4(ACSL4)、转铁蛋白受体1(TFR1)、铁蛋白重链1(FTH1)表达的情况。
结果
2
与空白组比较,CuB各给药组4T1细胞存活率明显下降(
P
<
0.05),细胞克隆数显著减少(
P
<
0.01),细胞LDH的泄漏显著增多(
P
<
0.01),细胞线粒体膜电位显著下降(
P
<
0.01),细胞ROS水平显著提升(
P
<
0.01)。与空白组比较,CuB各给药组细胞线粒体明显皱缩,线粒体嵴减少甚至消失。与空白组比较,CuB各给药组细胞p53、ACSL4、TFR1蛋白表达明显上调(
P
<
0.05),SLC7A11、GPX4、FTH1蛋白表达明显下调(
P
<
0.05)。
结论
2
CuB可能通过上调p53表达,抑制SLC7A11和GPX4表达,进而调控p53/SLC7A11/GPX4信号通路轴;通过上调ACSL4表达,加速脂质过氧化底物的产生,同时上调TFR1表达促进细胞摄取Fe
3+
,下调FTH1的表达,降低储铁能力,使细胞内的游离Fe
2+
水平上升,催化芬顿反应,产生过量的ROS,使抗氧化系统和铁代谢失衡,进而诱导4T1细胞铁死亡。
Objective
2
To explore the role of cucurbitacin B (CuB) in inducing ferroptosis in 4T1 cells and its mechanism.
Methods
2
The effects of CuB(0.2, 0.4, 0.8 μmol·L
-1
)on the proliferation ability of 4T1 cells
in vitro
were detected using
the methyl thiazolyl tetrazolium (MTT) assay. The clonogenic ability of 4T1 cells was detected by the plate cloning assay, and the levels of lactate dehydrogenase (LDH) in 4T1 cells were detected by the use of a kit. The mitochondrial membrane potential and reactive oxygen species (ROS) levels in 4T1 cells were detected by flow cytometry, and the mitochondrial ultrastructure of 4T1 cells was observed by transmission electron microscopy. The western blot was used to detect the expression of ferroptosis-related protein p53 in 4T1 cells, solute carrier family 7 member 11 (SCL7A11), glutathione peroxidase 4 (GPX4), long-chain acyl-CoA synthetase 4 (ACSL4), transferrin receptor protein 1 (TFR1), and ferritin heavy chain 1 (FTH1).
Results
2
Compared with that in the blank group, the survival rate of 4T1 cells in CuB groups was significantly decreased (
P
<
0.05), and the number of cell clones in CuB groups was significantly reduced (
P
<
0.01). In addition, compared with that in the blank group, the leakage of LDH in cells in CuB groups was significantly increased (
P
<
0.01), and the mitochondrial membrane potential of cells in CuB groups decreased significantly (
P
<
0.01). Cellular ROS levels were significantly elevated in CuB groups (
P
<
0.01). The mitochondria of cells in CuB groups were obviously wrinkled, and the mitochondrial cristae were reduced or even disappeared. Compared with that in the blank group, the protein expression of p53, ACSL4, and TFR1 were significantly up-regulated in CuB groups (
P
<
0.05), and that of SLC7A11, GPX4, and FTH1 were significantly down-regulated (
P
<
0.05).
Conclusion
2
CuB may inhibit SLC7A11 and GPX4 expression by up-regulating the expression of p53, which in turn regulates the p53/SLC7A11/GPX4 signaling pathway axis and accelerates the generation of lipid peroxidation substrate by up-regulating the e
xpression of ACSL4. It up-regulates TFR1 expression to promote cellular uptake of Fe
3+
and down-regulates the expression of FTH1 to reduce the ability of iron storage, resulting in an elevated free Fe
2+
level. It catalyzes the Fenton reaction, generates excess ROS, imbalances the antioxidant system and iron metabolism, and then induces ferroptosis in 4T1 cells.
BRAY F , LAVERSANNE M , SUNG H , et al . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2024 , 74 ( 3 ): 229 - 263 .
王晋慧 , 吕邵娃 , 李孟 , 等 . 中药有效成分体外抗乳腺癌作用机制的研究进展 [J]. 中国实验方剂学杂志 , 2020 , 26 ( 17 ): 197 - 203 .
WANG J H , LYU S J , LI M , et al . Anti-breast cancer mechanism of active ingredients of traditional Chinese medicine in vitro [J]. Chin J Exp Tradit Med Form , 2020 , 26 ( 17 ): 197 - 203 .
JAIN V , KUMAR H , ANOD H V , et al . A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer [J]. J Control Release , 2020 , 326 : 628 - 647 .
DAI C H , CHEN X , LI J B , et al . Transcription factors in ferroptotic cell death [J]. Cancer Gene Ther , 2020 , 27 ( 9 ): 645 - 656 .
DIXON S J , LEMBERG K M , LAMPRECHT M R , et al . Ferroptosis: An iron-dependent form of nonapoptotic cell death [J]. Cell , 2012 , 149 ( 5 ): 1060 - 1072 .
GE A , HE Q , ZHAO D , et al . Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis [J]. J Cell Mol Med , 2024 , 28 ( 1 ): e18044 .
LI Z Q , CHEN L N , CHEN C , et al . Targeting ferroptosis in breast cancer [J]. Biomark Res , 2020 , 8 ( 1 ): 58 .
宫辰 , 杨冰 , 周钰通 , 等 . 葫芦素抗肿瘤作用及其机制研究进展 [J]. 药物评价研究 , 2023 , 46 ( 2 ): 452 - 461 .
GONG C , YANG B , ZHOU Y T , et al . Research progress on the pharmacological effects and mechanisms of cucurbitacin against tumors [J]. Drug Eval Res , 2023 , 46 ( 2 ): 452 - 461 .
WANG K Y , YE H , ZHANG X B , et al . An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition [J]. Biomaterials , 2020 , 257 : 120224 .
LUO W W , ZHAO W W , LU J J , et al . Cucurbitacin B suppresses metastasis mediated by reactive oxygen species(ROS) via focal adhesion kinase(FAK) in breast cancer MDA-MB-231 cells [J]. Chin J Nat Med , 2018 , 16 ( 1 ): 10 - 19 .
L J H , LI C , CAO L , et al . Cucurbitacin B regulates lung cancer cell proliferation and apoptosis via inhibiting the IL-6/STAT3 pathway through the lncRNA XIST/miR-let-7c axis [J]. Pharm Biol , 2022 , 60 ( 1 ): 154 - 162 .
YUAN R Y K , ZHAO W T , WANG Q Q , et al . Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyr optosis [J]. Pharmacol Res , 2021 , 170 : 105748 .
AHMED A , KHALIFA N E , TALIB H , et al . Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells [J]. Front Pharmacol , 2023 , 14 : 1206981 .
GAO Y , ISLAM M S , TIAN J , et al . Inactivation of ATP citrate lyase by cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth [J]. Cancer Lett , 2014 , 349 ( 1 ): 15 - 25 .
ZHANG H Y , ZHAO B , WEI H Z , et al . Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer [J]. J Ethnopharmacol , 2021 , 287 : 114915 .
刘致远 , 曾瑾子 , 郑桐煜 , 等 . 葫芦素B诱导人结直肠癌细胞铁死亡的分子机制研究 [J]. 食品工业科技 , 2024 , 45 ( 8 ): 325 - 335 .
LIU Z Y , ZENG J Z , ZHENG T Y , et al . Molecular mechanisms of cucurbitacin B induced ferroptosis in human colorectal cancer cells [J]. Sci Technol Food Ind , 2024 , 45 ( 8 ): 325 - 335 .
李晶晶 . 抑制STAT3磷酸化增强葫芦素B对B16F10黑素瘤细胞的细胞毒作用 [D]. 广州 : 暨南大学 , 2012 .
LI J J . Suppression of STAT3 phosphorylation enhances the cytotoxicity of cucurbitacin B in B16F10 melanoma cells [D]. Guangzhou : Jinan University , 2012 .
AISWARYA S , VIKAS G , HARITHA N H , et al . Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of corallocarpus epigaeus exhibits anti-melanoma potential [J]. Front Oncol , 2022 , 12 : 989283 .
DUANGMANO S , DAKENG S , JIRATCHARIYAKUL W , et al . Antiproliferative effects of cucurbitacin B in breast cancer cells: Down-regulation of the c-Myc/hTERT/Telomerase pathway and obstruction of the cell cycle [J]. Int J Mol Sci , 2010 , 11 ( 12 ): 5323 - 5338 .
梁菁 . 葫芦素B通过改变细胞生物力学性质抑制乳腺癌细胞迁移和侵袭 [D]. 天津 : 天津医科大学 , 2019 .
LIANG Q . Cucurbitacin B inhibits the migration and invasion of breast cancer cells by altering the biomechanical properties of cells [D]. Tianjin : Tianjin Medical University , 2019 .
刘磊 , 贾少晗 , 于鹏 . 线粒体在铁死亡中的形态特征和作用 [J]. 中国生物化学与分子生物学报 , 2023 , 39 ( 6 ): 769 - 777 .
LIU L , JIA S H , YU P . Morphological characteristics and the role of mitochondria in ferroptosis [J]. Chin J Biochem Mol Biol , 2023 , 39 ( 6 ): 769 - 777 .
JIANG X J , STOCKWELL B R , CONRAD M . Ferroptosis: Mechanisms, biology and role in disease [J]. Nat Rev Mol Cell Biol , 2021 , 22 ( 4 ): 266 - 282 .
刘思齐 , 杨正飞 , 江山平 . 铁死亡的发生机制及在脓毒症多器官功能障碍中的作用 [J]. 中华急诊医学杂志 , 2022 , 31 ( 11 ): 1558 - 1563 .
LIU S Q , YANG Z F , JIANG S P . The pathogenic mechanisms of ferroptosis in multiple organ dysfunction induced by sepsis [J]. Chin J Emerg Med , 2022 , 31 ( 11 ): 1558 - 1563 .
LIU Y Q , GU W . p53 in ferroptosis regulation: The new weapon for the old guardian [J]. Cell Death Differ , 2022 , 29 ( 5 ): 895 - 910 .
张慧中 , 倪健 , 彭胡麟玥 , 等 . 重楼皂苷Ⅱ诱导肝癌HepG2细胞铁死亡作用机制 [J]. 中国实验方剂学杂志 , 2024 , 30 ( 17 ): 105 - 112 .
ZHANG H Z , NI J , PENG H L Y , et al . Mechanism of polyphyllin Ⅱ in induction of ferroptosis in hepatocellular carcinoma HepG2 cells [J]. Chin J Exp Tradit Med Form , 2024 , 30 ( 17 ): 105 - 112 .
蒋楠 , 杜立达 , 孔德文 , 等 . 胱氨酸/谷氨酸反向转运体作为药物靶点的研究进展 [J]. 药学学报 , 2022 , 57 ( 6 ): 1621 - 1629 .
JIANG N , DU L D , KONG D W , et al . Research progress of cystine/glutamate antiporter as drug targets [J]. Acta Pharm Sin B , 2022 , 57 ( 6 ): 1621 - 1629 .
FORCINA G C , DIXON S J . GPX4 at the crossroads of lipid homeostasis and ferroptosis [J]. Proteomics , 2019 , 19 ( 18 ): e1800311 .
何瑛珏 , 李洋 , 田仪督 , 等 . 重组新城疫病毒rL-RVG通过p53-YAP1-ACSL4通路诱导肺腺癌细胞铁死亡 [J]. 医学研究与战创伤救治 , 2024 , 37 ( 1 ): 14 - 22 .
HE Y Y , LI Y , TIAN Y D , et al . Recombinant Newcastle disease virus rL-RVG induces ferroptosis in lung adenocarcinoma cells through the p53 YAP1-ACSL4 pathway [J]. J Trauma , 2024 , 37 ( 1 ): 14 - 22 .
CUI J X , CHEN Y J , YANG Q N , et al . Protosappanin A protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4/FTH1 axis-dependent ferroptosis [J]. Adv Sci , 2024 , 11 ( 34 ): e2310227 .
ZHAO Y C , LI Y Q , ZHANG R F , et al . The role of erastin in ferroptosis and its prospects in cancer therapy [J]. Onco Targets Ther , 2020 , 13 : 5429 - 5441 .
罗成 , 叶远航 , 宁博 , 等 . 中药调控铁死亡干预肺癌的研究进展 [J]. 中国实验方剂学杂志 , 2024 , doi: org/10.13422/j.cnki.syfjx.20241222 http://dx.doi.org/org/10.13422/j.cnki.syfjx.20241222 .
LUO C , YE Y H , NING B , et al . Research progress of Chinese medicine regulating ferroptosis in intervention of lung cancer [J]. Chin J Exp Tradit Med Form , 2024 , doi: org/10.13422/j.cnki.syfjx.20241222 http://dx.doi.org/org/10.13422/j.cnki.syfjx.20241222 .
VINCENT U , AXEL W , DANIEL A , et al . Distribution of ferritin complex in the adult brain and altered composition in neuroferritinopathy due to a novel variant in the ferritin heavy chain gene FTH1 (c.409_410del; p.H137Lfs*4) [J]. Brain Pathol , 2023 , 34 ( 1 ): e13176 .
TIAN Y , LU J , HAO X , et al . FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson's disease [J]. Neurotherapeutics , 2020 , 17 ( 4 ): 1796 - 1812 .
WANG H H , LIU X D , ChEN Y , et al . The regulatory role of miR-21 in ferroptosis by targeting FTH1 and the contribution of microglia-derived miR-21 in exosomes to arsenic-induced neuronal ferroptosis [J]. J Hazard Mater , 2024 , 478 : 135580 .
张艺博 , 张慧中 , 阮意丹 , 等 . 重楼总皂苷诱导乳腺癌MCF-7细胞铁死亡抗肿瘤机制研究 [J]. 中国中药杂志 , 2024 , 49 ( 9 ): 2385 - 2392 .
ZHANG Y B , ZHNAG H Z , RUAN Y D , et al . Anti-tumor mechanism of total saponins of Paridis Rhizoma on inducing ferroptosis of breast cancer MCF-7 cells [J]. China J Chin Mater Med , 2024 , 49 ( 9 ): 2385 - 2392 .
0
Views
167
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621